Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
104.09
-0.78 (-0.74%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
30
31
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
July 06, 2022
Upgrades
Via
Benzinga
Could This Company's Gastrointestinal Drug Be A Powerful Pill For People And Animals With Chronic, Debilitating Diarrhea?
June 27, 2022
San Francisco-based Jaguar Health, Inc. (NASDAQ: JAGX), a commercial-stage pharmaceuticals company, says it is focused on developing novel, plant-based, non-opioid and sustainably derived prescription...
Via
Benzinga
Amazon.com To $180? Here's The Biggest Price Target Changes For Friday
June 24, 2022
Piper Sandler cut Accenture plc (NYSE: ACN) price target from $368 to $305. Accenture shares gained 4.2% to trade at $297.69 on Friday.
Via
Benzinga
Abbott Restarts Baby Formula Plant
June 06, 2022
Abbott shut-down its Sturgis, MI, plant in February as the Food and Drug Administration investigated the deaths of two infants who succumbed to bacterial infections.
Via
Talk Markets
What 6 Analyst Ratings Have To Say About Abbott Laboratories
June 24, 2022
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Here's How Much $1000 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
June 24, 2022
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 7.3% on an annualized basis producing an average annual return of 17.14%. Currently, Abbott Laboratories has a market...
Via
Benzinga
Benzinga Before The Bell: Tesla's Cybertruck Update, Twitter's New Feature, Netflix's Ad-Tier And Other Top Financial Stories Thursday, June 23
June 23, 2022
CNBC Pilot Shortage Pushes American Airlines To Quit Services In 4 Cities
Via
Benzinga
FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens
June 23, 2022
Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at...
Via
Benzinga
What It Means For US Stocks To Be In A Bear Market
June 22, 2022
Wall Street has officially fallen into a bear market as investor sentiment is hammered by soaring inflation, rising interest rates and worries about a looming recession in the...
Via
Benzinga
Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16
June 16, 2022
Wall Street Journal Moderna Plans COVID-19 Vaccine Trial For Infants
Via
Benzinga
More Trouble For Baby Formula Production As Thunderstorms, Flood, Hit Abbott's Troubled Michigan Plant
June 16, 2022
Via
Benzinga
3 Dividend Stocks to Buy Now for 20 Years of Income Growth
June 10, 2022
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts.
Via
InvestorPlace
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
June 09, 2022
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world.
Via
Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
June 09, 2022
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road.
Via
InvestorPlace
7 Monkeypox Stocks That May Take Off in Q2
June 09, 2022
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.
Via
InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,900 Today
June 08, 2022
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.54% on an annualized basis producing an average annual return of 14.5%. Currently, Abbott Laboratories has a...
Via
Benzinga
Analyzing Abbott Laboratories's Short Interest
June 08, 2022
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.48% since its last report. The company recently reported that it has 13.46 million shares sold short, which is...
Via
Benzinga
5 Analysts Have This to Say About Abbott Laboratories
June 07, 2022
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
SOBRsafe CEO Reports Boosting Holdings In Company
June 06, 2022
Photo by Vinicius "amnx" Amano on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Dave Gandini is...
Via
Benzinga
Abbott Stock Looks To Emerge From Bear Market Stronger
June 01, 2022
Abbott stock also has a 92 Composite Rating, placing it in the top 8% for a group of five key ratings, including EPS.
Via
Investor's Business Daily
Australia, New Zealand Express Support To Address USA Baby Food Crisis
June 01, 2022
Australia is in talks with the U.S. to supply baby food, Reuters reports.
Via
Benzinga
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
May 31, 2022
The deal would have been transformative, but may have limited teamwork in the space.
Via
Investor's Business Daily
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much
May 27, 2022
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 2.65% on an annualized basis producing an average annual return of 14.68%. Currently, Abbott Laboratories has a...
Via
Benzinga
Quant Ratings Updated on 75 Stocks
May 26, 2022
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy.
Via
InvestorPlace
Lawmakers Seek Answers From FDA, Abbott On Nationwide Baby Formula Shortage
May 26, 2022
FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE: ABT) recalled some baby formula products and closed its manufacturing plant in...
Via
Benzinga
FDA Allows Import Of 2M Baby Formula Cans Amid Supply Shortage: Reuters
May 25, 2022
The FDA is easing regulations to allow infant formula imports from Britain, bringing around 2 million cans onto empty shelves by June to ease a nationwide shortage, Reuters...
Via
Benzinga
Could This Technology Help Drastically Lower America's Alcohol Abuse In Workplaces?
May 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Of the 10 common addictions in the U.S., alcohol ranks...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, May 25
May 25, 2022
Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims
Via
Benzinga
More Companies Join Race To Ease US Baby Formula Supply Crunch
May 25, 2022
Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide...
Via
Benzinga
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
May 24, 2022
One analyst called the rumored deal "transformative," but says the timing is unfavorable.
Via
Investor's Business Daily
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.